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Some medicinal herbs and compounds are known to target cancer cells, but the suc-
cess of them as anticancer compounds depends to a large extent on their ability to ac-
tivate pathways that kill cancer cells by arresting cell cycle and inducing apoptosis. The
aim of the present study was to determine the anticancer effects of Euphorbia szovitsii
Fisch. & C.A.Mey. on the breast cancer cells to reveal the underlying mechanism of its
anti-breast cancer properties. In this experimental study, triple negative breast cancer cell
line (MDA-MB-231) was cultivated in RPMI-1640 medium. Hydroalcoholic extract (70:30) of
aerial parts of the plant was prepared. The cultured cells were treated with different con-
centrations (0–1000 μg/ml) of E. szovitsii extract for 24 and 48 h. Toxicity of the extract
on MDA-MB-231 cells was examined using MTT (3-[4,5-dimethyl-2-thiazolyl]-2, 5 diphenyl
tetrazolium bromide) test. The Annexin V–FITC Apoptosis Detection Kit was used to evaluate
apoptosis and necrosis. Flow cytometry technique was employed to differentiate different
phases of the cell cycle in the cells. Data were analyzed by GraphPad Prism and SPSS soft-
ware. After 24 and 48 h, the IC50 values were respectively 76.78 (95% CI = 60.75–97.05;
R = 0.8588) and 59.71 (95% CI = 46.25–77.09; R = 0.8543) μg/ml for E. szovitsii. The
extract exhibited antiproliferative effects against MDA-MB-231 cells in a dose-dependent
manner. Annexin V-FITC/PI assay confirmed that the extract was able to induce apoptosis
in MDA-MB-231 cells. Moreover, treatment with the extract resulted in cell cycle arrest at G1
phase. Therefore, E. szovitsii could induce apoptosis and cycle arrest in the MDA-MB-231
cell line. It might be a good resource of natural products for producing anti-breast cancer
drugs.
Introduction
Breast cancer is the most common cancer in women around the world. It is the leading cause of cancer
death in less developed countries. According to the global cancer project (2012), nearly 1.7 million new
cases of breast cancer have been diagnosed (12% of all new cancer cases) and 521,907 cases of deaths due
to breast cancer occurred in the world [1,2].
Despite the many drugs used to treat breast cancer, the incidence and prevalence of this cancer is still
high. Besides that, many of the chemical drugs used to treat breast cancer lead to several side effects that
limit their use for patients. Meanwhile, the production of drugs with higher efficacy and fewer side effects
have always been taken into account. Medicinal plants are one of the most important natural resources of
the options offered by researchers and pharmacists and, if they are used at certain doses, they will show
the highest compatibility with the immune system. Medicinal plants, in many cases, have antioxidant and
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anti-inflammatory properties that can reduce the side effects of chemical drugs [3,4]. In previous studies on the
anticancer effects of medicinal plants in Chaharmahal and Bakhtiari province, a plant from the Euphorbia family,
namely, E. szovitsii Fisch. & C.A.Mey., was among the plants that exhibited anticancer effects on various cancers such
as breast cancer. In addition, in examining cells under treatment, significant morphological changes were observed,
including major changes in the normal state of cell membrane and cell granulation, shrinkage of the membrane of
the nucleus, and decrease in the cell volume. In addition, a number of cells have been isolated from the flask floor
and floated.
In this paper, we have evaluated the anticancer effects from E. szovitsii on the MDA-MB-231 cells to determine
the underlying mechanism of its anticancer effects.
Experimental
Cell culture
Triple negative breast cancer cell line (MDA-MB-231 cells) was purchased from Pasteur Institute, Iran-Tehran. The
cells were grown in RPMI-1640 medium at 37◦C in a humidified atmosphere with 5% CO2, 95% air. The medium
was refreshed every 24 h, and the cells were trypsinized (0.1% trypsin) on reaching 80% confluency.
Preparation of the herbal extract
E. szovitsii was collected from Saman in Chaharmahal and Bakhtiyari province and air dried in the shade at
RT (25◦C). The plant was authenticated by Dr Shirmardi (Research Center for Agricultural & Natural Resources,
Shahrekord, Iran). A voucher specimen was prepared and deposited in Herbarium unit of Shahrekord University of
Medical Sciences (Skums-935). The aerial parts were ground by a mechanical grinder. The hydroalcoholic extract
(alcohol:water = 70:30) of the plant was provided using maceration method at room temperature. The extract was
then filtered throughWhatman paper no. 40, and the resultant filtrate was evaporated under negative pressure using
a rotary vacuum evaporator.
Cell viability assay
For evaluating the cell viability, MDA-MB231 cells were exposed to a wide concentration range of the E.
szovitsii extract (0–1000 μg/ml). Toxicity of the extract on breast cancer cells was examined using MTT
(3-[4,5-dimethyl-2-thiazolyl]-2, 5 diphenyl tetrazolium bromide) assay 24 and 48 h after seeding.
Briefly, 7 × 103 cells were seeded into each well of a 96-well plate. After 24 h, the attached cells were treated with
different concentrations (0–1000 μg/ml) of E. szovitsii extract in two time intervals (24 and 48 h). The negative
control was not treated with any concentration of E. szovitsii extract. After incubation, supernatant was discarded
and the attached cells rinsed with PBS. Then, 100MTT solution (2mg/ml PBS) was added to each well and incubated
4 h at 37◦C. Eventually, supernatant of each well was removed again, mixed with 200 μl of DMSO and gently shaked
for a while to subsequently keep in dark place.
The cell viability of the treated cells was measured at 570 nm by Stat-Fax 2100 microplate reader (Awareness Tech-
nology Inc) and the calculated according to the following equation:




For evaluating the apoptosis assay, the flow cytometry technique was used. MDA-MB231 cells were seeded in six-well
plates at a density of approximately 120× 103 cells. Twenty-four hours after seeding, the cells were exposed with IC50
values of E. szovitsii extract. The treated cells were harvested after 24 and 48 h, rinsed twice with cold PBS. The pellet
(at a concentration of 106 cells/ml) resuspended in 500μl BindingBuffer (1×), and incubatedwith 5μl FITC-Annexin
V and 5 μl PI. The samples were gently vortexed and incubated for 15 min at room temperature in the dark. About
400 μl of 1× Binding Buffer was added to each tube [5]. One hour after incubation, flow cytometric technique was
performed by a flow cytometer (CyFlow, Partec, Munster, Germany). The results were analyzed using FCS Express 5
reader (De Novo Software).
Cell cycle assay
For calculating the content of DNA in various phases of cell cycle, the cells were seeded into six-well plate and treated
with IC50 values of E. szovitsii extract 24 h after seeding. Cell cycle assay was conducted according to the standard
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Figure 1. Microscopic photos of triple negative breast cancer cell line (MDA-MB231) treated with the Euphorbia szovitsii
Fisch. & C.A.Mey. extract
(A) Control cells (none treated cells); (B) Treated by 50 μg/ml of E. szovitsii after 24 h; (C) Treated by 50 μg/ml of E. szovitsii after 48
h; (D) Treated by 100 μg/ml of E. szovitsii after 24 h; (E) Treated by 100 μg/ml of E. szovitsii after 48 h.
protocol 24 and 48 h after treatment. Briefly, 5 × 105 treated cells were incubated with 250 μl of trypsin buffer (as
Solution A) and 200 μl of trypsin inhibitor with RNase buffer (as Solution B) at 20–25◦C for 10 min, respectively.
Then, 200 μl of cold PI stain solution (as Solution C) was added and incubated in the dark for 10 min on ice [6].
Finally, the samples were read via a flow cytometer (CyFlow, Partec, Munster, Germany), and data were analyzed
through FCS Express 5 reader (De Novo Software).
Statistical analysis
The IC50 values were determined using GraphPad Prism 6.0 software through regression analysis. ANOVA (one-way
analysis of variance) was used to compare the data. P<0.05 was considered significant.
Results
E. szovitsii extract indicated cytotoxic effects on MDA-MB231 cells obviously. The extract exhibited cytotoxic ef-
fects on breast cancer cell line in a dose-dependent manner (Figure 1). The IC50 values were gained 76.78 (95%
CI = 60.75–97.05; R = 0.8588) and 59.71 (95% CI = 46.25–77.09; R = 0.8543) μg/ml 24 and 48 h after treatment,
respectively (Figure 2).
E. szovitsii induced apoptosis in breast cancer cell line
In order to apoptosis evaluation, MDA-MB231 cells were treated with 50 (as minimum concentration of IC50 value)
and 100 μg/ml (as maximum concentration of IC50 value) of E. szovitsii extract. Flow cytometry technique via FITC
Annexin V Apoptosis Detection Kit II was used to determine necrotic and apoptotic cells. In this method, Annexin
V-FITC positive and PI negative cells were considered as early apoptotic cells (Q4); Annexin V-FITC positive and PI
positive cells were considered as late apoptotic cells (Q2); and Annexin V-FITC negative and PI positive cells were
considered as necrotic cells (Q1) (Figure 3).
Sum of early apoptotic cells and late apoptotic cells was calculated as the rate of apoptosis. The results indicated an
increase in apoptotic cells in 24 and 48 h after treatment via IC50 values of the E. szovitsii extract (Figure 4).
E. szovitsii arrested cell cycle in breast cancer cell line
DNA content was analyzed in different phases of the cell cycle and percentage of the cells in any phases was compared
with the control groups (Figure 5). Treatment of breast cancer cell line with E. szovitsii extract caused an increase
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Figure 2. Cell viability evaluation of triple negative breast cancer cell line (MDA-MB231) treated with the Euphorbia szovitsii
Fisch. & C.A.Mey. hydroalcoholic extract
Figure 3. Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic extract induces apoptosis in the MDA-MB231 cells
(A) Control cells (none treated cells) after 24 h; (B) Treated by 50 μg/ml of E. szovitsii after 24 h; (C) Treated by 100 μg/ml of E.
szovitsii after 24 h; (D) Control cells (none treated cells) after 48 h; (E) Treated by 50 μg/ml of E. szovitsii after 48 h; (F) Treated by
100 μg/ml of E. szovitsii after 48 h. Q4: early apoptotic cells (Annexin V-FITC positive, PI negative); Q2: late apoptotic cells (Annexin
V-FITC positive, PI positive); Q1: necrotic cells (Annexin V-FITC negative, PI positive).
in the percentage of the cells at the G1 phase; whereas a decrease was seen in the cell population at the S phase. G2
phase indicated a decrease until 48 h, but after 48 h it indicated an increase in proportion compared with the control
cells. The cells treated with 50 and 100 μg/ml of E. szovitsii after 48 h showed a decrease in proportion of the cells in
G2/M (Table 1). Percentage of the cells in different phases of the cell cycle in treated cells was significantly different
from them in the control group (P<0.05).
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Figure 4. The rate of apoptosis in treated MDA-MB231 cells with Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic
extract
C: Control; E50: E. szovitsii with 50 μg/ml concentration; E100: E. szovitsii with 100 μg/ml concentration.
Figure 5. Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic extract arrest cell cycle in the MDA-MB231 cells
(A) Control cells (none treated cells) after 24 h; (B) Treated by 50 μg/ml of E. szovitsii after 24 h; (C) Treated by 100 μg/ml of E.
szovitsii after 24 h; (D) Control cells (none treated cells) after 48 h; (E) Treated by 50 μg/ml of E. szovitsii after 48 h; (F) Treated by
100 μg/ml of E. szovitsii after 48 h.
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Table 1 Percentage of the MDA-MB231 cells treated with Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic extract in
different phases of the cell cycle
Groups G1 (%) S (%) G2 (%) G2/G1
24 h Control 43.23 39.06 17.71 1.92
E50 58.25 30.01 11.74 1.91
E100 62.09 22.78 15.14 1.93
48 h Control 54.35 36.32 9.33 1.98
E50 67.58 18.89 13.54 1.92
E100 69.18 13.38 17.44 1.89
E50, E. szovitsii with 50 μg/ml concentration; E100, E. szovitsii with 100 μg/ml concentration.
Discussion
In present study that designed to evaluate the anticancer effects of E. szovitsii on the MDA-MB-231 cells and to
determine the underlying mechanism of its anticancer effects, the studied plant could induce apoptosis and arrest
cell cycle in the breast cancer cell line.
Today, one of the interesting strategies that has been considered in cancer chemotherapy is drug interventions that
can mediate the death of malignant cells by inducing apoptosis. In the present study, the extract of E. szovitsii both
higher and lower than IC50 concentrations, was able to kill the cancer cells by inducing apoptosis. The plant was able
to exhibit its apoptotic effect even after 24 h, and there was no significant difference in apoptosis between 24 and
48 h after treatment. So far, many medicinal plants and compounds have been observed to show anticancer effects
by inducing apoptosis. Although many plants are able to induce apoptosis, in some studies, the extracts have been
observed to induce death through the necrosis pathway, which limits their use to some extent. In addition, most of the
plants evaluated in the previous studies have shown greater apoptotic effects after 48 h [7–11]. Based on the results
of the present and previous studies, this plant may be considered as one of the potential anticancer plants due to its
anti-apoptotic effects after 24 h, as well as the low rate of necrosis induction.
In cancer cells, the regulation of the cell cycle control points was disturbed, resulting in a decrease in the percentage
of cells, in particular the cells present in the G1/G0 phase, and the percentage of the cells present in the S phase [12].
In our study, the anticancer effect of the extract on cell cycle phases may suggest that the extract at both lower and
higher than IC50 levels can arrest the cell cycle in the G1 phase and also decrease the amount of cells in the S phase.
In the study of Choene et al., the growth inhibiting effects of the E. turicalli extract on different breast cell lines
including MDA-MB 231 and MCF-7 were investigated. The plant extract exhibited growth inhibiting effects in cell
type- and concentration-dependent manner after 48 h and arrested the cell cycle in the G0/G1 phase due to excessive
expression of p21 [13]. Studies have shown plants that are selectively able to arrest the cell cycle in a particular phase
can be a good choice for anticancer therapies, and compounds that arrest the cell cycle during the G1/S transitional
phase are typically nucleotide synthesis inhibitors [14]. These results indicate that the plant extract, as a nucleotide
synthesis inhibitor, can be a good choice to develop anticancer drugs especially to treat breast cancer. In the study of
Choene and Motadi, various types of secondary metabolites including flavonoids and terpenes in E. tirucalli were
reported, and the anticancer effects of this plant were attributed to these compounds [13].
In Iran, Zare et al. investigated the chemical composition of another species of the Euphorbia genus, namely, E.
macrostegia, and observed that the plant had awide range of active compounds, including tertipanes and unsaturated
fatty acids, which can have anticancer effects [15]. Specifically, the anticancer effects of other compounds such as
jolkinolide B, euphoscopin, euphohelioscopin, euphorninA, helioscopinolide, steroids and triterpenes obtained from
different species of the Euphorbia genus have been studied on various breast cancer cells and their positive effects have
been confirmed [16–19]. The results of the present and previous studies indicate that the species of the Euphorbia
genus may be able to exert anticancer effects due to the presence of terpenoid compounds.
Conclusion
E. szovitsii indicated anti-breast cancer effects with visible morphological changes on theMDA-MB231 cell line. The
extract could induce apoptosis and cell cycle arrest in the MDA-MB-231 cell line. We believe that E. szovitsii extract
can be considered as a proper candidate for cancer therapy. It should be evaluated in in vivo studies and human
clinical trials for producing an anti-breast cancer drug.
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